Nalbuphine+Naloxone, solution for injection

Sale

Description

1. An entirely new combination. An original analgesic, which is not a scheduled drug.


2. The combination is in complete compliance with a global trend of multimodal analgesia. 


3.  The option for adequate pain control (equivalent to morphine) achieved with low doses and with minimal complications and adverse effects.


 


The conditions for licensing-out selling of the product.


1. Documents to be transferred:  


-     Pharmaceutical development in a CTD layout;


-    Module 3 in a CTD layout;


-    Scientific publications, literature reviews;


-    The recommended justified market price, market situation and the tentative sales targets; 


3. The generated samples for transfer and for the conduction of pre & clinical trials;


4.   The option for a technology transfer with on-site visits of specialists to the manufacturing site;


More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 949

Advertiser details

olxxx xxxxx show
Contact Advertiser

Add comment

 
Related adverts
 

Phone number

Sorry, you need to register or login first.

Email

Sorry, you need to register or login first.

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favorites

Sorry, you need to register or login first.

Advert search